HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
KLOW BlendHPLC ≥ 99%MS confirmed80mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | KLOW Blend |
|---|---|
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 80mg |
| Documentation | Batch-linked COA containing chromatographic purity and molecular-weight identity results for the confirmed lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture; long-term storage at -20°C or below. After reconstitution keep refrigerated at 2-8°C and use within a short window. Avoid repeated freeze-thaw cycles. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About KLOW Blend.
KLOW Blend is a physical combination of four distinct research peptides — the copper tripeptide GHK-Cu, the gastric pentadecapeptide BPC-157, the thymosin-β4 fragment TB-500, and the tripeptide KPV. It is supplied as a single-vial format grouping four separately studied research targets (collagen remodeling, tissue-repair signaling, cell migration and inflammation modulation) rather than as one defined molecular entity.
Documentation
Batch documentation support for KLOW Blend lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the KLOW Blend reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
KLOW Blend — frequently asked by B2B buyers.
What is in KLOW Blend and in what ratio?
The standard KLOW composition is GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg, blended to 80mg total per lyophilized vial. Custom ratios or alternate totals can be produced to specification on RFQ.
Does KLOW Blend have a single CAS number or molecular weight?
No. KLOW is a physical blend of four distinct peptides, so it has no single CAS number, molecular formula or molecular weight. We can supply authoritative per-component identifiers and documentation for GHK-Cu, BPC-157, TB-500 and KPV individually.
What documentation ships with each batch?
The batch COA lists all four components and reports chromatographic purity, component molecular-weight identity, water content and blend composition. Current-batch documentation can be reviewed before order confirmation.
What format, vial size and MOQ do you offer?
KLOW is offered as an 80mg neutral lyophilized vial with a standard MOQ of 1 kit (10 vials). Neutral labeling is default; custom labels, branded packaging and private-label OEM services are available on request.
Is KLOW Blend for research use only?
Yes. It is supplied strictly for B2B, laboratory and research use — not for consumer use, therapeutic or diagnostic use. Buyers are responsible for confirming import and regulatory compliance in their destination market.
Related compounds
Related research peptides.
Current Batch COA
Open the KLOW Blend Certificate of Analysis.
Batch-linked COA PDF for each KLOW Blend specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.